AI-based programmatic marketing platform, Doceree has announced the launch of its new initiative called The NEXT Marketing Lab to help the life sciences industry. 

The company’s latest launch addresses challenges in the pharmaceutical sector: data intricacies, especially rigid data silos, that hinder commercial team collaboration, informed decision-making, next-gen research, and clinical transformation.  

“The pharma landscape has evolved drastically with the industry waking up to the new reality of digital and incorporating the same into its fold to target HCPs across online platforms. The new scenario is a lot different from how data was traditionally collected in a controlled manner. The digital push has led to innumerable, vast, and unstructured HCP datasets that are difficult to exploit for valuable insights that can drive key business decisions to make HCP communications more effective in terms of precision, timing, and relevancy,” said Harshit Jain MD, founder and global CEO, Doceree. 

"The lab will facilitate marketers to use and share data with ease and work with HCP datasets holistically to enhance internal and external collaborations to support innovation. This is the kind of value creation we aim to make for our partners as we assist them in their business growth," he added.

“Doceree’s The NEXT Marketing Lab is designed to help marketers not only explore transformational data opportunities, but also to cross the chasm between innovative ideas and impactful market solutions,” said Kate Miller, executive vice President of Strategy at Doceree.

Founded in 2018, the start-up raised $ 11 million in April, 2022. The company facilitates messaging between life sciences brands and HCPs through an extensive global network of digital endemic and point-of-care platforms to programmatically deliver personalized communications to HCPs and transparent marketing campaign metrics at scale